Company
Fluid Biotech
0 Followers
Fluid Biotech is commercializing the first bioabsorbable brain stent to cure aneurysms
About
Fluid Biotech is commercializing the first bioabsorbable brain stent to cure aneurysms. Brain aneurysms afflict up to 5% of people and can lead to devastating stroke.
Company
Aug 2026